Woodline Partners LP 13D/13G Filings for Eledon Pharmaceuticals, Inc. (ELDN)

Woodline Partners LP 13D and 13G filings for Eledon Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
07:20 am
Purchase
2021-12-3113GEledon Pharmaceuticals, Inc.
ELDN
Woodline Partners LP685,273
4.800%
685,273increase
(New Position)
Filing